Back

Cardiotoxic receptor tyrosine kinase inhibitors exert toxic effects on human cardiac stem cells and impair cardiac function

27 August 2017 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Cardiac regeneration and repair Stem cells and cell therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Andrew Smith

University of Leeds, Leeds (United Kingdom of Great Britain & Northern Ireland)

34 More presentations in this session

Presentation thumbnail
Associate Professor D. D'Amario (Novara, IT)
Abstract
Presentation thumbnail
Miss I. Borrego (Fribourg, CH)
Abstract
Presentation thumbnail
Doctor J. Abe (Sapporo, JP)
Abstract
Presentation thumbnail
Miss E. Andre (Brussels, BE)
Abstract
Presentation thumbnail
Doctor Y. Mu (Urumqi, CN)

Access the full session

Session thumbnail
Poster session 3 - Cardiac regeneration and repair

The Event

Event poster

ESC Congress 2017

27 August 2017 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Direct effects of the tyrosine kinase inhibitors (TKIs) nilotinib and imatinib on the myocardium: clues towards cardiotoxic profiles
20 June 2025
thumbnail
Webinar
How to organise cardiovascular monitoring during cancer treatment: who, when and how. ESC 2022 Clinical Practice Guidelines - Webinar Series
26 September 2022
thumbnail
Congress Presentation
Identifying a cardioprotective agent using human quadricellular cardiovascular organoids for modelling chemotherapy-induced cardiomyopathy.
22 May 2023
thumbnail
Congress Presentation
Adverse cardiovascular events associated with kinase inhibitors and the prognostic value of imaging – a single-center retrospective cohort study in cancer patients
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources